Among participants who met the core RESTORE-ALS Trial criteria (e.g., baseline serum NfL > 33 pg/mL, TRICALS risk score range between –6.5 and –2.5, baseline slow vital capacity > 60%, and symptom ...
A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
StudyFinds on MSN8d
Breakthrough blood test could transform ALS diagnosis, careFind out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.
Denali Therapeutics’ amyotrophic lateral sclerosis (ALS) drug has racked up another clinical miss this year, leaving the ...
A charity hockey game is on the way to Western Michigan University's (WMU) Lawson Ice Arena this spring. Hosted by the Susan ...
Despite being diagnosed with Amyotrophic Lateral Sclerosis, or ALS, a longtime coach at Northern Bedford County High School ...
ALS impacts tens of thousands of people across the United States, and hundreds in Arizona. There's research being done in the ...
A blood test can help doctors detect ALS, or amyotrophic lateral sclerosis, and predict how the degenerative disease will ...
Woolsey Pharmaceuticals has secured additional funds to continue advancing its ROCK inhibitor Bravyl (oral fasudil) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback